CDEK
← All organizations

Sprout Pharmaceuticals

For profitContributed to NME

Also known as: Sprout | Sprout Pharmaceuticals, Inc | SPROUT PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2011

First marketed drug

Aug 18, 2015

First NDA

Aug 18, 2015

Last known activity

Jun 30, 2019

Acquired by Bausch Health Companies on Aug 20, 2015

Timeline

2010s

  1. Jan 1, 2011

    Sprout Pharmaceuticals— Founded

  2. Aug 18, 2015

    flibanserin— NDA Organization

  3. Aug 18, 2015

    flibanserin— NDA Secondary Org

  4. Aug 20, 2015

    Bausch Health Companies— Acquired By

Drugs by trial phase (2 distinct, 14 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (18)

Details

Founded
Raleigh, NC, US Jan 1, 2011
First NDA
Aug 18, 2015
Last known activity
Jun 30, 2019

Notes

Acquired by Valeant 20 Aug 2015